Targeting PD-L1 in non-small cell lung cancer using CAR T cells

Ming Liu(First Affiliated Hospital of Guangzhou Medical University), Yong Li(Baylor College of Medicine)
Oncogenesis
August 13, 2020
10.1038/s41389-020-00257-z
Cited by 90

Related Papers

miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
|Journal of Hematology & Oncology|2018|133
p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB
|Oncology Reports|2015|73
Leucovorin Enhances the Anti-cancer Effect of Bortezomib in Colorectal Cancer Cells
|Scientific Reports|2017|38
Expanding anti-CD38 immunotherapy for lymphoid malignancies
|Journal of Experimental & Clinical Cancer Research|2022|35
Ubiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation
|Journal of Hematology & Oncology|2020|30